97 related articles for article (PubMed ID: 34542089)
1. Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
Perkins RB; Guido RS; Castle PE; Chelmow D; Einstein MH; Garcia F; Huh WK; Kim JJ; Moscicki AB; Nayar R; Saraiya M; Sawaya GF; Wentzensen N; Schiffman M;
J Low Genit Tract Dis; 2021 Oct; 25(4):330-331. PubMed ID: 34542089
[No Abstract] [Full Text] [Related]
2. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors: Erratum.
J Low Genit Tract Dis; 2020 Oct; 24(4):427. PubMed ID: 32732649
[No Abstract] [Full Text] [Related]
3. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
4. The 2006 consensus guidelines for the management of women with abnormal cervical screening tests: challenges remain.
Colgan TJ
Cancer Cytopathol; 2010 Oct; 118(5):233-7. PubMed ID: 20629030
[TBL] [Abstract][Full Text] [Related]
5. 2001 Consensus guidelines for the management of women with cervical intraepithelial neoplasia.
Wright TC; Cox JT; Massad LS; Carlson J; Twiggs LB; Wilkinson EJ;
J Low Genit Tract Dis; 2003 Jul; 7(3):154-67. PubMed ID: 17051063
[TBL] [Abstract][Full Text] [Related]
6. The Effect of the 2012 ASCCP Consensus Guideline for Abnormal Cervical Cytology on Resident Colposcopy Training.
Hirai CM; Kaneshiro B; Hiraoka MK
Hawaii J Med Public Health; 2018 Jan; 77(1):3-6. PubMed ID: 29333334
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for screening and treatment of cervical disease in the adolescent.
Guido R
J Pediatr Adolesc Gynecol; 2004 Oct; 17(5):303-11. PubMed ID: 15581775
[TBL] [Abstract][Full Text] [Related]
8. Making Sense of Cervical Cancer Screening Guidelines and Recommendations.
Davis M; Feldman S
Curr Treat Options Oncol; 2015 Dec; 16(12):55. PubMed ID: 26467929
[TBL] [Abstract][Full Text] [Related]
9. ASCCP patient management guidelines: Pap test specimen adequacy and quality indicators.
Davey DD; Austin RM; Birdsong G; Buck HW; Cox JT; Darragh TM; Elgert PA; Hanson V; Henry MR; Waldman J;
Am J Clin Pathol; 2002 Nov; 118(5):714-8. PubMed ID: 12428791
[TBL] [Abstract][Full Text] [Related]
10. Preparing for the Next Round of ASCCP-Sponsored Cervical Screening and Management Guidelines.
Schiffman M; Wentzensen N; Khan MJ; Castle PE; Chelmow D; Huh WK; Moscicki AB; Stockdale CK; Darragh TM; Silver M; Guido RS
J Low Genit Tract Dis; 2017 Apr; 21(2):87-90. PubMed ID: 28244885
[No Abstract] [Full Text] [Related]
11. Cervical cancer screening.
Partridge EE; Abu-Rustum N; Giuliano A; Massad S; McClure J; Dwyer M; Hughes M;
J Natl Compr Canc Netw; 2014 Mar; 12(3):333-41; quiz 341. PubMed ID: 24616539
[TBL] [Abstract][Full Text] [Related]
12. Benefits of Cervical Cancer Screening by Liquid-Based Cytology as Part of Routine Antenatal Assessment.
Parkpinyo N; Inthasorn P; Laiwejpithaya S; Punnarat T
Asian Pac J Cancer Prev; 2016; 17(9):4457-4461. PubMed ID: 27797261
[TBL] [Abstract][Full Text] [Related]
13. Participants at the ASCCP 2000 Biennial Meeting adhere to published guidelines in their management of atypical squamous cells and atypical glandular cells on pap test.
Ancheta E; Perry J; Bernard-Pearl L; Paul S; Darragh T; Smith-McCune K
J Low Genit Tract Dis; 2003 Oct; 7(4):279-84. PubMed ID: 17051084
[TBL] [Abstract][Full Text] [Related]
14. Current Cervical Carcinoma Screening Guidelines.
Schlichte MJ; Guidry J
J Clin Med; 2015 May; 4(5):918-32. PubMed ID: 26239455
[TBL] [Abstract][Full Text] [Related]
15. Improving the Accuracy of a Clinical Decision Support System for Cervical Cancer Screening and Surveillance.
Ravikumar KE; MacLaughlin KL; Scheitel MR; Kessler M; Wagholikar KB; Liu H; Chaudhry R
Appl Clin Inform; 2018 Jan; 9(1):62-71. PubMed ID: 29365341
[TBL] [Abstract][Full Text] [Related]
16. ASCCP Patient Management Guidelines: Pap Test Specimen Adequacy and Quality Indicators.
Davey DD; Austin RM; Birdsong G; Buck HW; Cox JT; Darragh TM; Elgert PA; Hanson V; Henry MR; Waldman J
J Low Genit Tract Dis; 2002 Jul; 6(3):195-9. PubMed ID: 17051020
[TBL] [Abstract][Full Text] [Related]
17. Practice Bulletin No. 157 Summary: Cervical Cancer Screening and Prevention.
Obstet Gynecol; 2016 Jan; 127(1):185-187. PubMed ID: 26695578
[TBL] [Abstract][Full Text] [Related]
18. Human Papillomavirus Testing by Veterans Administration Women's Health Providers: Are They Adhering to Guidelines?
Hallett LD; Gerber MR
J Womens Health (Larchmt); 2018 Feb; 27(2):179-182. PubMed ID: 28885082
[TBL] [Abstract][Full Text] [Related]
19. Secondary prevention of cervical cancer part 1: screening for cervical cancer and its precursors.
Boisen M; Diedrich JT; Lonky NM; Guido R
Clin Obstet Gynecol; 2014 Jun; 57(2):279-91. PubMed ID: 24785416
[TBL] [Abstract][Full Text] [Related]
20. Assessment of follow-up for low-grade cytological abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000-2005.
Benard VB; Howe W; Saraiya M; Helsel W; Lawson HW
J Low Genit Tract Dis; 2008 Oct; 12(4):300-6. PubMed ID: 18820545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
